HI F pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma. - Maroto, P.; Esteban, E.; Fernández Parra, E.; Mendez-Vidal, M. J.; Domenech, M.; Pérez-Valderrama, B.; Calderero, V.; Pérez-Gracia, J. L.; Grande, E.; Algaba, F. (OncoTargets & Therapy, 2017)